146 related articles for article (PubMed ID: 32270348)
1. Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1.
Ye M; Han R; Shi J; Wang X; Zhao AZ; Li F; Chen H
Med Oncol; 2020 Apr; 37(5):43. PubMed ID: 32270348
[TBL] [Abstract][Full Text] [Related]
2. CYP24A1-induced vitamin D insufficiency promotes breast cancer growth.
Osanai M; Lee GH
Oncol Rep; 2016 Nov; 36(5):2755-2762. PubMed ID: 27600601
[TBL] [Abstract][Full Text] [Related]
3. Low CYP24A1 mRNA expression and its role in prognosis of breast cancer.
Cai H; Jiao Y; Li Y; Yang Z; He M; Liu Y
Sci Rep; 2019 Sep; 9(1):13714. PubMed ID: 31548577
[TBL] [Abstract][Full Text] [Related]
4. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells.
Liao CF; Luo SF; Li LT; Lin CY; Chen YC; Jiang MC
J Exp Clin Cancer Res; 2008 Jul; 27(1):15. PubMed ID: 18597698
[TBL] [Abstract][Full Text] [Related]
5. Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development.
Behrens P; Brinkmann U; Fogt F; Wernert N; Wellmann A
Anticancer Res; 2001; 21(4A):2413-7. PubMed ID: 11724300
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
[TBL] [Abstract][Full Text] [Related]
7. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY
Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578
[TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA BC200 (BCYRN1) is critical for cancer cell survival and proliferation.
Booy EP; McRae EK; Koul A; Lin F; McKenna SA
Mol Cancer; 2017 Jun; 16(1):109. PubMed ID: 28651607
[TBL] [Abstract][Full Text] [Related]
9. SIRT7 depletion inhibits cell proliferation, migration, and increases drug sensitivity by activating p38MAPK in breast cancer cells.
Chen KL; Li L; Yang FX; Li CM; Wang YR; Wang GL
J Cell Physiol; 2018 Sep; 233(9):6767-6778. PubMed ID: 29231244
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
11. Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells.
Chen CF; Dou XW; Liang YK; Lin HY; Bai JW; Zhang XX; Wei XL; Li YC; Zhang GJ
Cell Cycle; 2016; 15(3):432-40. PubMed ID: 26694515
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissues.
Zhalehjoo N; Shakiba Y; Panjehpour M
Mol Med Rep; 2017 Jan; 15(1):467-473. PubMed ID: 27922682
[TBL] [Abstract][Full Text] [Related]
13. 17beta-hydroxysteroid dehydrogenase type 5 is negatively correlated to apoptosis inhibitor GRP78 and tumor-secreted protein PGK1, and modulates breast cancer cell viability and proliferation.
Xu D; Aka JA; Wang R; Lin SX
J Steroid Biochem Mol Biol; 2017 Jul; 171():270-280. PubMed ID: 28457968
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle.
Yang M; Gao H; Chen P; Jia J; Wu S
Oncol Rep; 2013 Jul; 30(1):171-8. PubMed ID: 23624618
[TBL] [Abstract][Full Text] [Related]
15. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
Song W; Thakor P; Vesey DA; Gobe GC; Morais C
Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
[TBL] [Abstract][Full Text] [Related]
16. Identification of vitamin D
Sheng L; Anderson PH; Turner AG; Pishas KI; Dhatrak DJ; Gill PG; Morris HA; Callen DF
J Steroid Biochem Mol Biol; 2016 Nov; 164():90-97. PubMed ID: 26485663
[TBL] [Abstract][Full Text] [Related]
17. Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo.
Aziz MH; Chen X; Zhang Q; DeFrain C; Osland J; Luo Y; Shi X; Yuan R
Oncotarget; 2015 Nov; 6(37):39714-24. PubMed ID: 26492163
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
19. Regulatory effects of ΔFosB on proliferation and apoptosis of MCF-7 breast cancer cells.
Li H; Li L; Zheng H; Yao X; Zang W
Tumour Biol; 2016 May; 37(5):6053-63. PubMed ID: 26608367
[TBL] [Abstract][Full Text] [Related]
20. Chronic moderate ethanol intake differentially regulates vitamin D hydroxylases gene expression in kidneys and xenografted breast cancer cells in female mice.
García-Quiroz J; García-Becerra R; Lara-Sotelo G; Avila E; López S; Santos-Martínez N; Halhali A; Ordaz-Rosado D; Barrera D; Olmos-Ortiz A; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2017 Oct; 173():148-156. PubMed ID: 27639478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
